HepaticexpressionofscavengerreceptorclassBtypeI(SR-BI)isapositiveregulatorofmacrophagereversecholesteroltransportinvivo
...sylvania,USA.AbstractHepaticexpressionofthescavengerreceptorclassBtypeI(SR-BI)promotesselectiveuptakeofHDLcholesterolbytheliverandisbelievedtoplayaroleintheprocessofreversecholesteroltransport(RCT).WehypothesizedthathepaticSR-BIexpressionisaregulatoroftherateofintegratedmacrophage-to-fecesRCTandused...
医源资料库;在线期刊;临床研究杂志;2005年第115卷第10期鸡蛋壳中钙含量的测定
...将鸡蛋壳灰化后,将钙质转化为氯化钙,用乙二胺四醋酸二钠(0.05mmol/L)滴定液滴定测得含钙(Ca)量为26.99%(g/g)。该方法的回收率为99.57%,RSD=0.5%(n=5)。现将测定方法报告如下。1试剂与仪器乙二胺四醋酸二钠滴定液(C=0.05...
合作平台;在线期刊;中华实用医药杂志;2004年第4卷第2期;其他RelativeContributionsofABCA1andSR-BItoCholesterolEffluxtoSerumFromFibroblastsandMacrophages
...tohumanserum.MethodsandResults-HumanfibroblastswerestablytransfectedwithSR-BIwhileABCA1wasupregulated.Quantitationofcholesteroleffluxtohumanserumdemonstratedthattherewaseffluxfromcellswithouteitherprotein.ExpressionofABCA1producedasmallincreaseinefflux,whereasSR-BIexpressionhadadramaticimpact.Toquan...
医源资料库;在线期刊;动脉硬化血栓血管生物学杂志;2006年第26卷第3期Cholesterolbinding,efflux,andaPDZ-interactingdomainofscavengerreceptor–BImediateHDL-initiatedsignaling
...ia,Pennsylvania,USA.5DepartmentofMedicine,DivisionofMolecularMedicine,ColumbiaUniversityCollegeofPhysiciansandSurgeons,NewYork,NewYork,USA.AbstractThebindingofHDLtoscavengerreceptor–BI(SR-BI)mediatescholesterolmovement.HDLalsoinducesmultiplecellularsignals,whichinendotheliumoccurthroughSR-BIandcon...
医源资料库;在线期刊;临床研究杂志;2005年第115卷第4期氯屈膦酸二钠胶囊
正式名:氯屈膦酸二钠胶囊 汉语拼音:LuqulinsuanErna 标准号:WS-023(X-021)-98 拉丁文或英文:DisodiumClodronate 主要活性成分:二氯亚甲基双膦酸二钠四水合物,按干燥品计算,含CH2Cl2Na2O6P2不得少于98.0%。 性状:...
药品天地;专业药学;药品质量标准;西药第五部分DifferentialAdditiveEffectsofEndothelialLipaseandScavengerReceptor-ClassBTypeIonHigh-DensityLipoproteinMetabolisminKnockoutMouseModels
...crinologyandMetabolism(K.M.,L.C.),DepartmentsofMedicineandMolecularCellularBiology,BaylorCollegeofMedicine,andSt.Luke’sEpiscopalHospital,Houston,Tex;LawrenceBerkeleyNationalLaboratory(T.F.),Berkeley,Calif;andLipoScience(J.D.O.),Raleigh,NC.CorrespondencetoLawrenceChan,DivisionofEndocrinologyMetabol...
医源资料库;在线期刊;动脉硬化血栓血管生物学杂志;2005年第25卷第1期CholesterylEsterTransferProtein(CETP)ExpressionProtectsAgainstDietInducedAtherosclerosisinSR-BIDeficientMice
...ssionofthehumanCETPtransgeneprotectsagainstdiet-inducedatherosclerosisinSR-BIdeficientmice.MethodsandResults-SR-BIdeficient(-/-)micewerecrossedwithCETPtransgenic(CETPtg)micetoproduceacolonyofSR-BI-/-xCETPtgmiceinaC57Bl/6background.Ageandsexmatchedgroupsofgeneticallymodifiedandwild-typeC57Bl/6micewer...
医源资料库;在线期刊;动脉硬化血栓血管生物学杂志;2007年第27卷第4期血液滤过置换液
...无水硫酸钠10g,研磨均匀,即得)少许,用乙二胺四醋酸二钠液(0.05mol/L)滴定,至溶液自红色变为蓝色,即得。每1ml的乙二胺四醋酸二钠液(0.05mol/L)相当于7.351mg的CaCl2·2H2O。氯化镁精密量取本品200ml,加氨-氯化铵缓冲液(PH1...
药品天地;专业药学;药品质量标准;西药第八部分MacrophageApolipoproteinEReducesAtherosclerosisandPreventsPrematureDeathinApolipoproteinEandScavengerReceptor-ClassBIDouble-KnockoutMice
...】Objective-Micenullforbothapolipoprotein(apo)Eandscavengerreceptor(SR)-BI(DKO)developseverehypercholesterolemia,occlusivecoronaryatherosclerosis,myocardialinfarction,andprematuredeath.ThecurrentstudyexaminestheabilityofmacrophageapoEtoimprovethedyslipidemia,reduceatherosclerosis,andrescuethelethal...
医源资料库;在线期刊;动脉硬化血栓血管生物学杂志;2006年第26卷第1期HCV蛋白酶抑制剂BI201335有强效抗病毒活性
...林格殷格翰公司研发的丙肝病毒(HCV)NS3/4A蛋白酶抑制剂BI201335,在初治和经治的慢性基因1型丙肝病毒(HCV)感染患者中的优异疗效。基因1型的HCV是在所有HCV感染治疗中最有挑战性的基因分型。 丙型肝炎是肝脏感染性疾病...
行业资讯;临床快报;肝胆病